Corrigendum to ‘Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]
2020 ◽
Vol 26
(1)
◽
pp. 214
2017 ◽
Vol 23
(8)
◽
pp. 1311-1319
◽
2020 ◽
Vol 26
(1)
◽
pp. 215
2020 ◽
Vol 26
(1)
◽
pp. 213
2017 ◽
Vol 23
(8)
◽
pp. 1303-1310
◽